APGRX
Price
$24.99
Change
+$0.33 (+1.34%)
Updated
Sep 11 closing price
Net Assets
124.93M
RSLAX
Price
$68.33
Change
+$0.22 (+0.32%)
Updated
Sep 11 closing price
Net Assets
91.39B
Interact to see
Advertisement

APGRX vs RSLAX

APGRX vs RSLAX Comparison Chart in %
View a ticker or compare two or three
VS
APGRX vs. RSLAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGRX is a Buy and RSLAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLAX has more cash in the bank: 91.4B vs. APGRX (125M). RSLAX pays higher dividends than APGRX: RSLAX (0.17) vs APGRX (0.00). APGRX was incepted earlier than RSLAX: APGRX (13 years) vs RSLAX (24 years). RSLAX (1.74) is less costly to investors than APGRX (1.28). RSLAX is a more actively managed with annual turnover of: 41.00 vs. APGRX (38.00). RSLAX has a lower initial minimum investment than APGRX: RSLAX (250) vs APGRX (1000000). APGRX annual gain was more profitable for investors over the last year : 10.93 vs. RSLAX (7.36). APGRX return over 5 years is better than : 7.94 vs. RSLAX (-14.43).
APGRXRSLAXAPGRX / RSLAX
Total Expense Ratio1.261.7472%
Annual Report Gross Expense Ratio1.281.7474%
Fund Existence13 years24 years-
Gain YTD11.93811.723102%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets125M91.4B0%
Annual Yield % from dividends0.000.17-
Returns for 1 year10.937.36149%
Returns for 3 years48.7433.50146%
Returns for 5 years7.94-14.43-55%
Returns for 10 years60.3163.6795%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIEYX17.51N/A
N/A
GuideStone Funds International Eq Instl
SHRAX91.15N/A
N/A
ClearBridge Growth A
EAGCX16.22N/A
N/A
Eaton Vance Atlanta Capital Focused Gr C
TEIHX52.46N/A
N/A
Nuveen Equity Index I
BCEMX33.55N/A
N/A
Boston Common ESG Impact Em Mkts